Ariana V Cunningham is a Waco, Texas based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Ariana V Cunningham is K7707 for Ophthalmology in Texas. Ariana V Cunningham is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Ariana V Cunningham speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Female
Practice Address:
6901 Medical Pkwy, Waco, Texas, 76712-7910
Phone:
254-751-4020
Fax:
254-751-4024
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1962628503
NPI Enumeration Date:
18 Apr, 2007
NPI Last Update On:
09 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ariana V Cunningham are as mentioned below.
License Number
Specialization
State
Status
K7707
Ophthalmology
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6901 Medical Pkwy, Waco, Texas
Zip:
76712-7910
Phone Number:
254-751-4020
Fax Number:
254-751-4024
Patients can reach Ariana V Cunningham at 6901 Medical Pkwy, Waco, Texas or can call to book an appointment on 254-751-4020. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.